Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-012769
Filing Date
2015-02-27
Accepted
2015-02-27 16:30:43
Documents
15
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v402310_10k.htm 10-K 852604
2 EXHIBIT 10.16 v402310_ex10-16.htm EX-10.16 38493
3 EXHIBIT 21.01 v402310_ex21-01.htm EX-21.01 3557
4 EXHIBIT 23.01 v402310_ex23-01.htm EX-23.01 2338
5 EXHIBIT 31.01 v402310_ex31-01.htm EX-31.01 12464
6 EXHIBIT 31.02 v402310_ex31-02.htm EX-31.02 12609
7 EXHIBIT 32.01 v402310_ex32-01.htm EX-32.01 6658
14 GRAPHIC tex10-16pg7.jpg GRAPHIC 22444
15 GRAPHIC tex10-16pg9.jpg GRAPHIC 55073
  Complete submission text file 0001144204-15-012769.txt   5949905

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT tnxp-20141231.xml EX-101.INS 656995
9 XBRL TAXONOMY EXTENSION SCHEMA tnxp-20141231.xsd EX-101.SCH 61277
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tnxp-20141231_cal.xml EX-101.CAL 40746
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tnxp-20141231_lab.xml EX-101.LAB 394848
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tnxp-20141231_pre.xml EX-101.PRE 386687
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tnxp-20141231_def.xml EX-101.DEF 347899
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36019 | Film No.: 15659317
SIC: 2834 Pharmaceutical Preparations